Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Aveanna Healthcare Holdings's Beta is 2.9088.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aveanna Healthcare Holdings Beta vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's Beta distribution charts can be found below:
* The bar in red indicates where Aveanna Healthcare Holdings's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Aveanna Healthcare Holdings (AVAH) has a Beta of 2.9088 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Aveanna Healthcare Holdings and its competitors.
Is Aveanna Healthcare Holdings' Beta too high?
Aveanna Healthcare Holdings' current Beta is 2.9088. Overall, Aveanna Healthcare Holdings has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' Beta compare to AGL and SNDA?
Aveanna Healthcare Holdings' Beta of 2.9088 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Aveanna Healthcare Holdings and its competitors. Aveanna Healthcare Holdings's current Beta is 2.9088. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.16, compared to a current price of $8.66 — trading 67.8% above its estimated fair value. The current Beta is 2.9088. Aveanna Healthcare Holdings' overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current Beta is 2.9088 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued.
The current stock price of $8.66 is trading 67.8% above its estimated GF Value™ of $5.16.
GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.
Key valuation signals for AVAH:
Beta: 2.9088
GF Value™: $5.16 vs. price of $8.66 (67.8% above fair value)
No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
69GF Score
Get the complete analysis for AVAH
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAH has been successfully added to your 
